Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

153.53
BATS BZX Real-Time Price
As of 11:10am ET
 +0.21 / +0.14%
Today’s Change
95.14
Today|||52-Week Range
157.41
+36.25%
Year-to-Date
Closing the Door on Abiomed
Aug 16 / TheStreet.com - Paid Partner Content
Why ABIOMED (ABMD) Could Be Positioned for a Surge
Aug 10 / Zacks.com - Paid Partner Content
Castleark Management Llc Buys XPO Logistics Inc, Celgene Corp, Broadcom, Sells Panera...
Aug 15 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close153.32
Today’s open153.15
Day’s range152.98 - 153.60
Volume3,139
Average volume (3 months)308,218
Market cap$6.8B
Dividend yield--
Data as of 11:10am ET, 08/22/2017

Growth & Valuation

Earnings growth (last year)+37.65%
Earnings growth (this year)+84.81%
Earnings growth (next 5 years)+36.00%
Revenue growth (last year)+35.13%
P/E ratio90.4
Price/Sales12.56
Price/Book14.81

Competitors

 Today’s
change
Today’s
% change
DXCMDexCom Inc+3.02+4.13%
WSTWest Pharmaceutical ...+0.32+0.38%
MASIMasimo Corp+0.25+0.29%
TFXTeleflex Inc+0.02+0.01%
Data as of 11:14am ET, 08/22/2017

Financials

Next reporting dateNovember 2, 2017
EPS forecast (this quarter)$0.38
Annual revenue (last year)$445.3M
Annual profit (last year)$52.1M
Net profit margin11.70%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael R. Minogue
Chief Operating Officer
David M. Weber
Corporate headquarters
Danvers, Massachusetts

Forecasts